Trimethadione
Back to searchMolecule Structure
Scientific Name
Trimethadione
Description of the Drug
Trimethadione is an anticonvulsant agent indicated for the control of treatment-refractory petit mal seizures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00347
http://www.drugbank.ca/drugs/DB00347
Brand Name(s)
Tridione
Company Owner(s)
Abbvie Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Voltage-gated T-type calcium channel | PROTEIN FAMILY | BLOCKER | CHEMBL2362995 |
Clinical Trial(s)
Unichem Links
| Atlas | trimethadione |
| SureChEMBL | SCHEMBL28882 |
| PharmGKB | PA164744924 |
| Human Metabolome Database | HMDB0014491 |
| DrugBank | DB00347 |
| PubChem: Thomson Pharma | 14793827 |
| PubChem | 5576 |
| Mcule | MCULE-4761457520 |
| NMRShiftDB | 20180581 |
| LINCS | LSM-5345 |
| Nikkaji | J2.519D |
| BindingDB | 50227239 |
| EPA CompTox Dashboard | DTXSID9021396 |
| DrugCentral | 2751 |
| ChemicalBook | CB3477704 |
| Guide to Pharmacology | 7316 |
| rxnorm | TRIMETHADIONE |
| ChEBI | 9727 |
| ZINC | ZINC000001530710 |
